Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Pharm Des. 2005;11(27):3545-59.

Why drugs fail--a study on side effects in new chemical entities.

Author information

  • 1Institute of Pharmacy, Department of Pharmaceutical Chemistry, University of Innsbruck, Innrain 52, A-6020 Innsbruck, Austria.

Abstract

Over 90% of the market withdrawals were caused by drug toxicity. Hepatotoxicity and cardiovascular toxicity proved to be the major causes for two out of three market withdrawals in the respective time period. In clinical phases I-III 43% of drug development project terminations were due to insufficient efficacy of the investigated compound. The second important issue, which caused one third of the projects to be closed, was toxicity. ADME parameters and economic and other reasons played a minor role. The results of our study indicate that compared with previous studies on this subject, no major improvements have been achieved in the last decade.

PMID:
16248807
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Bentham Science Publishers Ltd.
    Loading ...
    Write to the Help Desk